Bishop, I'm with you, I look forward to the July revenue announcement early next week. Based on the previous 5 month track record of increasing growth, I look forward to July coming in just over $3M, a $36M annual run rate. There has been a lot of discussion about Mr. Schneiderman eventually making the announcement that SCRC is "Cash Flow Positive". This will be a major catalyst for the company and future investors. My gut tells me with the CFP statement, increasing revenues, and possibly even some good news concerning RapiMeds, that the value of the stock will rise to a substantial and sustainable level encouraging the flippers and/or manipulators will move on to another stock in the penny world. I am excited about the future of SCRC. I have taken advantage of these low prices and lowered my cost basis considerably over the last few months. From where I sit, it's all positive and how ever long it takes for all the revenue streams to come to fruition is okay with me. Back in February 2013 when I made my initial investment I was told Q3 - Q4 2014 would be the time frame to see SCRC come into it's own. Yes, there have been some changes to the business plan and even some bumps in the road, but I say, we are right on target.